Merck Historical Income Statement

0QAH Stock

USD 103.50 27.80 21.17%

Historical analysis of Merck income statement accounts such as Ebit of 11.8 B, Net Income Applicable To Common Shares of 11 B or Income Tax Expense of 1.2 B can show how well Merck Company performed in making a profits. Evaluating Merck income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Merck's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Merck Company latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Merck Company is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Merck Income Statement Analysis

Merck Company Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Merck shareholders. The income statement also shows Merck investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Merck Income Statement Chart

At this time, Merck's Tax Provision is quite stable compared to the past year. Interest Income is expected to rise to about 383.2 M this year, although the value of EBIT will most likely fall to about 11.8 B.

Discontinued Operations Income Tax Expense Tax Provision Selling General Administrative Total Revenue

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Merck Company generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most accounts from Merck's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Merck Company current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2020	2021	2023	2024 (projected)
EBIT	7.7B	13.9B	16.0B	11.8B
Discontinued Operations	2.5B	704M	633.6M	601.9M

Ebit Discontinued Operations

Merck income statement Correlations

	Discontinued Operations	Ebit	Income Tax Expense	Tax Provision	Net Interest Income	Interest Income	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Operating Income	Net Income From Continuing Ops	Research Development	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Minority Interest
Discontinued Operations		-0.7	0.7	-0.83	0.67	-0.71	-0.72	-0.9	-0.91	-0.93	-0.41	-0.27	-0.53	-0.79	-0.68	-0.57	-0.29	0.7	0.01	0.97
Ebit	-0.7		-0.17	0.62	-0.37	0.59	0.7	0.74	0.81	0.83	0.36	0.25	0.64	0.64	0.72	0.44	0.27	-0.61	0.0	-0.83
Income Tax Expense	0.7	-0.17		-0.49	0.69	-0.8	-0.68	-0.76	-0.63	-0.63	0.24	0.37	-0.57	-0.6	-0.65	-0.64	0.35	0.52	0.57	0.58
Tax Provision	-0.83	0.62	-0.49		-0.87	0.61	0.62	0.82	0.89	0.86	0.61	0.44	0.28	0.93	0.51	0.73	0.47	-0.88	0.18	-0.86
Net Interest Income	0.67	-0.37	0.69	-0.87		-0.77	-0.67	-0.82	-0.79	-0.75	-0.2	-0.03	-0.33	-0.9	-0.54	-0.86	-0.05	0.85	0.2	0.69
Interest Income	-0.71	0.59	-0.8	0.61	-0.77		0.96	0.92	0.85	0.85	-0.21	-0.39	0.85	0.82	0.93	0.87	-0.37	-0.78	-0.64	-0.72
Interest Expense	-0.72	0.7	-0.68	0.62	-0.67	0.96		0.89	0.89	0.89	-0.09	-0.28	0.91	0.85	0.98	0.87	-0.26	-0.84	-0.54	-0.73
Selling General Administrative	-0.9	0.74	-0.76	0.82	-0.82	0.92	0.89		0.97	0.97	0.14	-0.03	0.71	0.89	0.85	0.79	-0.01	-0.82	-0.33	-0.93
Total Revenue	-0.91	0.81	-0.63	0.89	-0.79	0.85	0.89	0.97		1.0	0.32	0.14	0.68	0.95	0.84	0.81	0.17	-0.9	-0.16	-0.94
Gross Profit	-0.93	0.83	-0.63	0.86	-0.75	0.85	0.89	0.97	1.0		0.31	0.14	0.7	0.92	0.84	0.77	0.17	-0.87	-0.16	-0.96
Operating Income	-0.41	0.36	0.24	0.61	-0.2	-0.21	-0.09	0.14	0.32	0.31		0.98	-0.35	0.33	-0.18	-0.01	0.98	-0.32	0.88	-0.43
Net Income From Continuing Ops	-0.27	0.25	0.37	0.44	-0.03	-0.39	-0.28	-0.03	0.14	0.14	0.98		-0.49	0.13	-0.35	-0.21	1.0	-0.11	0.95	-0.3
Research Development	-0.53	0.64	-0.57	0.28	-0.33	0.85	0.91	0.71	0.68	0.7	-0.35	-0.49		0.56	0.97	0.64	-0.47	-0.56	-0.69	-0.55
Cost Of Revenue	-0.79	0.64	-0.6	0.93	-0.9	0.82	0.85	0.89	0.95	0.92	0.33	0.13	0.56		0.75	0.92	0.16	-0.98	-0.14	-0.82
Total Operating Expenses	-0.68	0.72	-0.65	0.51	-0.54	0.93	0.98	0.85	0.84	0.84	-0.18	-0.35	0.97	0.75		0.78	-0.33	-0.73	-0.59	-0.7
Reconciled Depreciation	-0.57	0.44	-0.64	0.73	-0.86	0.87	0.87	0.79	0.81	0.77	-0.01	-0.21	0.64	0.92	0.78		-0.18	-0.94	-0.43	-0.58
Income Before Tax	-0.29	0.27	0.35	0.47	-0.05	-0.37	-0.26	-0.01	0.17	0.17	0.98	1.0	-0.47	0.16	-0.33	-0.18		-0.14	0.95	-0.32
Total Other Income Expense Net	0.7	-0.61	0.52	-0.88	0.85	-0.78	-0.84	-0.82	-0.9	-0.87	-0.32	-0.11	-0.56	-0.98	-0.73	-0.94	-0.14		0.13	0.72
Net Income	0.01	0.0	0.57	0.18	0.2	-0.64	-0.54	-0.33	-0.16	-0.16	0.88	0.95	-0.69	-0.14	-0.59	-0.43	0.95	0.13		0.0
Minority Interest	0.97	-0.83	0.58	-0.86	0.69	-0.72	-0.73	-0.93	-0.94	-0.96	-0.43	-0.3	-0.55	-0.82	-0.7	-0.58	-0.32	0.72	0.0

Click cells to compare fundamentals

Merck Account Relationship Matchups

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

How To Invest In Merck

Details

Is Merck Stock a good investment?

Details

What is Merck's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Merck Historical Income Statement

About Merck Income Statement Analysis

Merck Income Statement Chart

Tax Provision

Total Revenue

Merck income statement Correlations

Merck Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Discontinued Operations	Ebit
Net Income Applicable To Common Shares	Income Tax Expense
Tax Provision	Net Interest Income
Interest Income	Interest Expense
Selling General Administrative	Total Revenue
Gross Profit	Operating Income
Net Income From Continuing Ops	Research Development
Cost Of Revenue	Total Operating Expenses
Reconciled Depreciation	Income Before Tax
Total Other Income Expense Net	Net Income
Minority Interest

Gross Profit	+ 1.0	Total Revenue
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Total Operating Expenses	+ 0.98	Interest Expense
Net Income From Continuing Ops	+ 0.98	Operating Income
Income Before Tax	+ 0.98	Operating Income
Minority Interest	+ 0.97	Discontinued Operations

Total Other Income Expense Net	- 0.98	Cost Of Revenue
Minority Interest	- 0.96	Gross Profit
Total Other Income Expense Net	- 0.94	Reconciled Depreciation
Minority Interest	- 0.94	Total Revenue
Minority Interest	- 0.93	Selling General Administrative
Gross Profit	- 0.93	Discontinued Operations